BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CTN Dissemination Library - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CTN Dissemination Library
X-ORIGINAL-URL:https://ctnlibrary.org
X-WR-CALDESC:Events for CTN Dissemination Library
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261028T110000
DTEND;TZID=America/Los_Angeles:20261028T123000
DTSTAMP:20260928T170200Z
CREATED:20260916T223808Z
LAST-MODIFIED:20260928T170200Z
UID:8953-1793185200-1793190600@ctnlibrary.org
SUMMARY:WS Node: Therapeutic Potential of GLP-1 Receptor Agonists for Substance Use Disorders
DESCRIPTION:Presenter: Christian Hendershot\, PhD\, Keck School of Medicine\, University of Southern California (read more about Dr. Hendershot here) \n\nThis presentation will summarize emerging evidence for the efficacy of GLP-1 receptor agonists for substance use disorders. Recent and ongoing Phase 2 clinical trials will be reviewed\, and key clinical and implementation issues discussed. \n1.5 CME/CE available \nLearning objectives\n\n\nIdentify at least three (3) potential therapeutic benefits of GLP-1-based therapies for individuals with substance use disorder.\n\n\n\nDescribe at least three (3) common side effects and three (3) safety considerations for GLP-1-based therapies.\n\n\n\nExplain at least three (3) GLP-1-based therapies currently under evaluation for substance use disorder.\n\nAbout the presenter\nChristian Hendershot\, PhD\, is Professor of Population and Public Health Sciences and Psychiatry and the Behavioral Sciences at the Keck School of Medicine\, University of Southern California\, and Director of Clinical Research at the USC Institute for Addiction Science. His research utilizes clinical\, cognitive\, neuroscience and psychopharmacology methods to study the etiology and treatment of substance use disorders. His recent work has included early Phase 2 trials of incretin therapies for substance use disorder\, including NIDA-funded projects evaluating the efficacy of GLP-1 receptor agonists for cigarette smoking. \nThis session is sponsored by the CTN Western States Node and the Northwest and Pacific Southwest ATTCs.
URL:https://ctnlibrary.org/event/therapeutic-potential-of-glp-1-receptor-agonists-for-substance-use-disorders/
LOCATION:Webinar/Virtual
END:VEVENT
END:VCALENDAR